147459-52-7 Usage
Uses
Used in Pharmaceutical Research:
3-(Boc-aMino)-3-Methylpyrrolidine is utilized as a key intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs with potential therapeutic applications. Its Boc-protected amino group allows for selective reactions and subsequent deprotection to yield the desired amine functionalities in the final products.
Used in Organic Synthesis:
In the realm of organic synthesis, 3-(Boc-aMino)-3-Methylpyrrolidine is employed as a chiral auxiliary, facilitating asymmetric synthesis and enhancing the selectivity of reactions involving chiral centers. This application is crucial for the production of enantiomerically pure compounds, which are essential in many pharmaceutical and agrochemical applications.
Used in Medicinal Chemistry and Drug Discovery:
3-(Boc-aMino)-3-Methylpyrrolidine may also find potential applications in medicinal chemistry and drug discovery due to its unique structural features. Its ability to serve as a building block and chiral auxiliary can aid in the design and synthesis of novel bioactive molecules with potential therapeutic properties.
Check Digit Verification of cas no
The CAS Registry Mumber 147459-52-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,7,4,5 and 9 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 147459-52:
(8*1)+(7*4)+(6*7)+(5*4)+(4*5)+(3*9)+(2*5)+(1*2)=157
157 % 10 = 7
So 147459-52-7 is a valid CAS Registry Number.
147459-52-7Relevant academic research and scientific papers
PYRROLOPYRIDINES AS KINASE INHIBITORS
-
, (2009/12/23)
Compounds of Formula (I) are useful for inhibition of CHKl and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
CARBAMATE AND UREA INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1
-
, (2009/12/05)
This invention relates to novel compounds of the Formula I, II, III, IHa, NIb, IV, IVa, IVb, IVc, IVd, IVe, V, Va, Vb1 Vl, Vla, VIb, VII, Vila, VIIb, VIII, Vllla, VIIIb, IX, IXa, X, and Xa, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 β-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to Cortisol in a cell.
8-vinyl- and 9-ethinyl-quinolone-carboxylic acids
-
, (2008/06/13)
The invention relates to new 8-vinyl- and 8-ethinylquinolonecarboxylic acids, process for their preparation, and antibacterial agents and feed additives containing them.
